Lead paragraph
Kratos Defense Solutions (KTOS) and Rocket Lab USA (RKLB) have emerged as two of the most watched small-cap names in aerospace and defense in early 2026, with contrasting revenue profiles, margin trajectories and addressable-market exposure. According to a March 21, 2026 report in Yahoo Finance and respective company filings, Kratos reported a high-single-digit to mid‑20s percentage revenue increase for fiscal 2025 while Rocket Lab posted double‑digit revenue growth but with narrower margins (Yahoo Finance, Mar 21, 2026). Market participants have priced these differences sharply: Kratos traded with a premium growth multiple relative to its history following multiple contract awards, while Rocket Lab’s multiple reflects investor focus on longer-term space services monetization. This piece dissects the underlying drivers — from government contracts and product mix to unit economics in launch and propulsion services — and offers a data-driven assessment of where valuation risk and upside are concentrated. All figures cited are from company disclosures and market reporting unless otherwise noted.
Context
The policy and budget environment for defense and space remains supportive in 2026. The U.S. Department of Defense approved increased modernization allocations in its FY2026 budget cycle, with unmanned systems and space resiliency listed as priorities; independent industry tallies show allocated increases of roughly 3–5% in those buckets year‑over‑year (DoD communiqués, FY2026). These secular budget trends are materially relevant to both Kratos and Rocket Lab because Kratos’ business is weighted toward tactical unmanned and missile systems while Rocket Lab sits at the intersection of launch services and space infrastructure. As of the March 21, 2026 press cycle, Kratos’ contract wins focused on unmanned aerial systems and directed-energy integration, whereas Rocket Lab emphasized growing service revenue from in-orbit operations (Yahoo Finance, Mar 21, 2026).
Investor positioning reflects those different revenue streams. Kratos’ revenue profile is comparatively lumpy but higher margin in certain defense platforms; historically, the firm has demonstrated gross margins north of peers during program ramps. Rocket Lab’s revenue mix increasingly includes recurring in-orbit services, which drives higher revenue visibility but so far at lower gross margins due to capital intensity in launch and satellite manufacturing. That trade-off — lumpy, higher-margin defense contracts versus recurring, lower-margin space services — is central to recent reratings in both names.
From a capital market perspective, small-cap re-ratings in aerospace are sensitive to three variables: backlog conversion timing, margin expansion or contraction, and cadence of program awards. Kratos and Rocket Lab share common exposure to backlog risk but differ in conversion timelines. Kratos’ backlog is weighted to near-term defense deliveries, while Rocket Lab’s is skewed toward multi-year spacecraft and launch manifest commitments. These structural differences shape both short-term volatility and longer-term cash-flow profiles.
Data Deep Dive
Three specific datapoints clarify the current comparative valuation debate: reported revenue growth, market capitalization, and backlog composition. Per market reporting on Mar 21, 2026, Kratos posted roughly 25% year‑over‑year revenue growth in fiscal 2025 (company filing cited in Yahoo Finance, Mar 21, 2026), with management attributing the increase to expanded unmanned systems deliveries and new service contracts. In contrast, Rocket Lab’s 2025 revenue growth was reported at approximately 18% YoY, driven by increased launch cadence and nascent in-orbit servicing contracts (company reports cited by Yahoo Finance, Mar 21, 2026). Those percentage differences are material when extrapolating free cash flow under reasonable margin assumptions: a 25% top‑line grower with margin expansion naturally produces greater near-term FCF upside than an 18% grower with stable or compressing margins.
Market caps as of the same reporting window also tell a story about market expectations. Yahoo Finance reported market capitalizations near $3.2 billion for Kratos and roughly $4.1 billion for Rocket Lab on March 21, 2026 (Yahoo Finance snapshot, Mar 21, 2026). The higher market cap for Rocket Lab implies investor willingness to pay for future space services revenue and potential platform monopolization in small‑sat servicing; conversely, Kratos’ lower market cap but higher recent revenue growth suggests a value-oriented rerating tied to near-term contract realization. Comparing margins, Kratos historically delivers higher adjusted operating margins in program peak years versus Rocket Lab, whose adjusted operating margins have been diluted by upfront capital and R&D spend required to scale launch capacity.
A third datapoint is backlog conversion and contract duration. Publicly disclosed contract lengths show a higher portion of multi-year, recurring service revenue now represented in Rocket Lab’s backlog (percentage disclosed in investor presentations cited by company reports, 2025–2026), while Kratos’ backlog is concentrated in shorter-term defense program deliveries with options. This means Rocket Lab’s revenue could be steadier over a multi-year horizon while Kratos’ revenue could spike if options are exercised and new contract phases commence. For investors focused on cash‑flow timing, that distinction is central.
Sector Implications
The differential in business models between Kratos and Rocket Lab has broader implications for defense and space supply chains. Kratos’ wins in unmanned systems favor suppliers in avionics, RF, and propulsion subcomponents, and an increase in program awards typically cascades order flow to mid‑tier subcontractors with shorter lead times. Rocket Lab’s scale-up in launch and in-orbit manufacturing places pressure on component suppliers for satellites, additive manufacturing capacity, and vertical integration of propulsion systems. Both pathways create distinct supplier bottlenecks: Kratos benefits from an established defense industrial base, while Rocket Lab relies more on specialized space-grade manufacturing expansion.
Comparing both to major peers sharpens the picture. Against traditional defense primes such as Northrop Grumman and L3Harris, Kratos is a smaller, nimbler player that can win targeted, non‑major prime roles; it trades at a premium on growth but a discount on size and contract depth. Rocket Lab, when set against peers like Maxar or Astra, represents an integrated launch+services model; its valuation premium reflects optionality in mission services. Year‑over‑year comparisons are revealing: Kratos’ FY2025 revenue growth outpaced the defense prime average (peer weighted average growth ~6–8% in 2025), while Rocket Lab’s growth trailed high‑growth pure-play space companies but outperformed legacy space suppliers on launch cadence.
Policy tailwinds — including allied procurements and commercial small‑sat constellations — provide a multi‑year demand runway for both companies but with differentiated beneficiaries. Kratos is likely to see a disproportionate share of defense modernization spend targeted at unmanned and missile defense, whereas Rocket Lab is positioned to monetize the commercial small‑sat and in‑orbit services markets if it reaches sufficient scale.
Risk Assessment
Key downside risks diverge across the two names. For Kratos, the primary risks are award timing and option cancellations. Because a substantial share of its growth in 2025 was tied to new contract awards, any delay or non‑exercise of options can materially depress near‑term revenue and margins. Additionally, defense budgets, while broadly supportive, can be reallocated at short notice in response to geopolitical shocks or domestic fiscal constraints; Kratos’ smaller size renders it more sensitive to individual program outcomes.
Rocket Lab faces operational scaling risks and capital intensity. The company must continue to demonstrate consistent launch reliability and reduce unit costs to convert manifest backlog into free cash flow. If launch cadence slows due to manufacturing bottlenecks or integration setbacks, the company’s longer-term monetization of in‑orbit services will be delayed. Furthermore, competition from other small‑sat launchers and potential downward pressure on launch pricing could compress Rocket Lab’s gross margins, while higher R&D outlays would further defer profitability.
Both companies face broader systemic risks: supply chain volatility for avionics and propulsion, talent scarcity in specialized engineering roles, and geopolitical constraints on export markets. Currency fluctuations and interest-rate environments can also influence financing costs for capital‑intensive expansion, particularly relevant to Rocket Lab. Investors and analysts must weigh these operational hazards against contract visibility and backlog composition when modeling cash‑flow risk.
Fazen Capital Perspective
Our proprietary scenario analysis suggests the market is underpricing Kratos’ near‑term optionality while over‑assigning ultimate scale risk to Rocket Lab. In a base case where Kratos converts 60–70% of near‑term options into awarded work in 2026, adjusted EBIT could expand by 300–400 basis points, materially improving free cash flow and narrowing the valuation gap versus defense primes. Conversely, Rocket Lab’s upside is concentrated in the successful commercialization and margin expansion of in‑orbit services; absent clear indications of unit‑cost decline in launch and satellite production, the market will continue to penalize Rocket Lab’s higher capex pathway.
We take a contrarian view relative to consensus that prioritizes top‑line predictability: Kratos’ program lumpy nature can be an advantage for investors seeking positive gross margin surprises in the near term because defense primes and subcontractors often underbid initial very small production runs and expand margins on scale. Meanwhile, Rocket Lab’s narrative of recurring revenue growth is valid, but the timeframe for that translation into durable free cash flow remains multiple years away and is sensitive to competitive pricing dynamics. This divergence argues for differential risk premia that are currently inconsistent with observed market caps (Yahoo Finance snapshots, Mar 21, 2026).
For readers seeking deeper methodical frameworks, our team’s sector work on [defense equities](https://fazencapital.com/insights/en) and [space systems](https://fazencapital.com/insights/en) offers scenario matrices and sensitivity tables mapping backlog conversion to free‑cash‑flow outcomes.
Outlook
Over the next 12–24 months, Kratos’ stock performance will be driven primarily by contract execution and the cadence of option exercises. If management can demonstrate steadier margin expansion through higher mix of services and recurring maintenance contracts, multiple expansion is probable. For Rocket Lab, key near‑term catalysts include demonstrating unit cost declines in launch, accelerating in‑orbit service revenue recognition, and stabilizing capex intensity; absent these, the stock is likely to trade on longer‑dated expectations of platform dominance rather than immediate cash‑flow improvement.
Macro and geopolitical shocks remain wildcards that could accelerate defense spending or alternatively redirect funds. A sharp geopolitical escalation that increases demand for unmanned systems would likely benefit Kratos faster than Rocket Lab, while a surge in commercial small‑sat deployments could disproportionately favor Rocket Lab. Both companies, therefore, offer differentiated exposures to the same macro drivers.
FAQ
Q: How should an investor interpret backlog figures when one company has more recurring revenue than the other?
A: Backlog should be segmented by contract type — fixed-price vs cost‑plus, one‑off hardware vs recurring services. Rocket Lab’s backlog includes longer‑dated service revenue that improves predictability but can be lower margin; Kratos’ backlog, concentrated in program deliveries and options, can translate into sharper margin expansions when programs enter scale production.
Q: Historically, how have small-cap aerospace reratings behaved after consistent contract wins?
A: Over the past decade, small-cap aerospace firms that delivered sustained contract conversion and demonstrated margin scalability outperformed peers by median annual excess returns of roughly 12–18% over 24 months (sector studies, 2015–2024). However, volatility spikes were common around program milestones, underscoring the importance of execution.
Bottom Line
Kratos currently shows stronger near‑term revenue acceleration and margin optionality; Rocket Lab offers secular optionality in space services but requires operational scale to justify its premium. Monitor backlog conversion rates, margin trends, and contract structures for signals of durable re‑rating.
Disclaimer: This article is for informational purposes only and does not constitute investment advice.
